tiprankstipranks

Bryan Ball Insider Profile

4 Followers
Bryan Ball, Chief Quality Officer at Immunomedics, holds 448.13K shares in Whitehawk Therapeutics (Ticker: WHWK), holds 25.18K shares in Intercept Pharma (Ticker: ICPT), holds 0.00 shares in Immunomedics (Ticker: IMMU).
tipranks
Bryan Ball

Bryan Ball
Immunomedics (IMMU)
Chief Quality Officer

Ranked #3,303 out of 107,514 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

+158.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Bryan Ball's holdings

Insider Roles

Whitehawk Therapeutics
(WHWK)
Chief Technical Operations Officer
Roles that Bryan Ball holds in companies

Most Profitable Insider Trade

Stock:
Immunomedics
(IMMU)
Rating:Informative Buy
Date:Oct 03, 2019 - Oct 03, 2020
Return:+501.60%
The most profitable trade made by Bryan Ball

Bryan Ball's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
IMMU
Immunomedics
Oct 23, 2020
Uninformative Sell
$0.00
ICPT
Intercept Pharma
Jul 13, 2022
Uninformative Sell
6.35K
$478.38K
Whitehawk Therapeutics
May 18, 2026
Chief Technical Operations Officer
Uninformative Buy
200.00K
$2.01M
List of latest transactions for each holding click on a transaction to see Bryan Ball's performance on stock

Bryan Ball insider profile FAQ

What is the percentage of profitable transactions made by Bryan Ball?
The percentage of profitable transactions made by Bryan Ball is 50%.
    What is the average return per transaction made by Bryan Ball?
    The average return per transaction made by Bryan Ball is 158.20%.
      What stocks does Bryan Ball hold?
      Bryan Ball holds: IMMU, ICPT, WHWK stocks.
        What was Bryan Ball’s latest transaction?
        Bryan Ball latest transaction was an Uninformative Buy of $200.00K.
          What was Bryan Ball's most profitable transaction?
          Bryan Ball’s most profitable transaction was an Informative Buy of IMMU stock on October 3, 2019. The return on the trade was 501.60%.
            What is Bryan Ball's role in Immunomedics?
            Bryan Ball's role in Immunomedics is Chief Quality Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.